Hormone therapy for prostate cancer increases cardiac risk

Androgen-deprivation therapy, which is a common treatment for prostate cancer, has been tentatively linked with an increased risk of cardiovascular disease. A new study solidifies these concerns. Although the findings are controversial, some studies have shown that androgen-deprivation therapy combined with radiotherapy is more successful at treating prostate cancer than just radiotherapy alone.
Medical News Today